+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein |
Clonality | Monoclonal |
Clone | M809 |
Reactivity | Virus |
Tested Applications | ELISA, WB, LF |
Host | Mouse |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | Recombinant SARS-CoV-2 Nucleocapsid Protein |
Isotype | IgG1 |
Form | Liquid |
Purity | > 95% (SDS-PAGE) |
Purification | Purified by Protein A affinity chromatography. |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
Buffer | PBS, pH 7.4, 0.05% NaN3. |
Specificity | Specific for SARS-CoV-2 Nucleocapsid Protein. Does not cross-react with MERS-CoV, Human CoV (NL63, 229E, OC43), Human Adenovirus (type 1, 3, 5, 7, 8, 11, 18, 23), Human Parainfluenza Virus (type 1, 2, 3, 4), Human Rhinovirus (type 1, 14, 42), Human Metapneumovirus, Respiratory Syncytial Virus A or Respiratory Syncytial Virus B. Cross-reacts with SARS-CoV (SARS 2003). |
Concentration | 3.13 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | This product is for research use only. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |